ASX ANNOUNCEMENT 3 November 2026 A R O A A P P O I N T S M A R K D U N W O O D I E A S C H I E F F I N A N C I A L O F F I C E R Highlights ? Mark Dunwoodie appointed Chief Financial Officer and Joint Company Secretary, effective 16 November 2026. ? More than 25 years of financial, strategic, and...
AROA Appoints Mark Dunwoodie as CFO
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Aroa Biosurgery Ltd has announced the appointment of Mark Dunwoodie as Chief Financial Officer and Joint Company Secretary, effective mid-November. This appointment supports a smooth transition from the outgoing CFO, James Agnew, who will leave the company at the end of November. CEO Brian Ward expressed confidence in Dunwoodie's ability to contribute to Aroa's growth strategy, particularly in the United States.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Aroa Biosurgery
- Change in substantial shareholding for ARX
- Molnlycke to Co-promote Endoform In the US
- Notification of cessation of securities - ARX
- Investor Presentation - Symphony RCT
- Invite to Investor Webinar on Symphony RCT
Later from Aroa Biosurgery
All Aroa Biosurgery news releasesFollow Aroa Biosurgery into a list and get an email when it puts out news.
Follow Aroa Biosurgery